149632-73-5

Basic information

• Product Name: Carbamic acid, (2-amino-1-methylethyl)-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, (2-amino-1-methylethyl)-, 1,1-dimethylethyl ester (9CI);2-tert-butoxycarbonyl aMinopropylaMine;tert-Butyl (1-aMinopropan-2-yl)carbaMate;2-N-BOC-propane-1,2-diamine;Carbamic acid, (2-amino-1-methylethyl)-, 1,1-dimethylethyl ester
• CAS NO: 149632-73-5
• Molecular Formula: C₈H₁₈N₂O₂
• Molecular Weight: 174.24072
• Product Categories: N-BOC
• Mol File: 149632-73-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 263.7±23.0 °C(Predicted)
• Appearance: /
• Density: 0.984±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• Solubility: Chloroform, Methanol (Sparingly)
• PKA: 12.19±0.46(Predicted)
• CAS DataBase Reference: Carbamic acid, (2-amino-1-methylethyl)-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (2-amino-1-methylethyl)-, 1,1-dimethylethyl ester (9CI)(149632-73-5)
• EPA Substance Registry System: Carbamic acid, (2-amino-1-methylethyl)-, 1,1-dimethylethyl ester (9CI)(149632-73-5)

Safety Data

• Hazardous Substances Data: 149632-73-5(Hazardous Substances Data)

Usage

General Description

Carbamic acid, (2-amino-1-methylethyl)-, 1,1-dimethylethyl ester (9CI) is a chemical compound commonly known as tert-butyl carbamate. It is an organic compound with the molecular formula C6H13NO2 and is used in various industrial and research applications. Tert-butyl carbamate is used as a reagent in organic synthesis and as a protecting group for amines in chemical reactions. It is also used in the production of pharmaceuticals, agrochemicals, and in the manufacturing of polymers. Tert-butyl carbamate is a colorless liquid with a faint odor and is considered to be stable under normal conditions, making it a versatile and valuable chemical in various industries.

Upstream product

• 149602-64-2 1-azido-2-(N-tert-butoxycarbonylamino)propane 
• 78981-25-6 tert-butyl (1-amino-1-oxopropan-2-yl)carbamate 
• 3744-87-4 N-t-butyloxycarbonyl-DL-alanine 
• 147252-84-4 tert-butyl (1-hydroxypropan-2-yl)carbamate 
• 6627-89-0 tert-butyl phenyl carbonate 
• 78-90-0 1,2-diaminopropan 
• 129319-71-7 (+/-)-N-(tert-Butoxycarbonyl)-2-methylaziridine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 769969-61-1 (2R,5S)-1-benzyl-5-(2-tert-butoxycarbonylamino-propylcarbamoyl)pyrrolidine-2-carboxylic acid ethyl ester 
• 1056117-87-3 [2-(2-Amino-phenylamino)-1-methyl-ethyl]-carbamic acid tert-butyl ester 
• 170116-52-6 N-(2'-tert-butylcarbamatopropyl)-2-nitroaniline 

Relevant articles and documents

Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents

A series of novel carbazole-containing amides and ureas were synthesized. A structure–activity relationship study of these compounds led to the identification of potent cryptochrome modulators. Based on the desired pharmacokinetic/pharmacodynamic parameters and the results of efficacy studies in db/db mice, compound 50 was selected for further profiling.

MACROCYCLIC RIP2 KINASE INHIBITORS

The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.

Compounds specific to adenosine A1 receptors and uses thereof

This invention pertains to compounds which specifically inhibit the adenosine A1 receptor and the use of these compounds to treat a disease associated with A1 adenosine receptors in a subject.